The Queen Mary Hospital, located in Pok Fu Lam on Hong Kong Island of Hong Kong, is the public district general hospital and teaching hospital of the Faculty of Dentistry and Li Ka Shing Faculty of Medicine of the University of Hong Kong. It has 1,706 beds.

There are 1,711 beds in Queen Mary Hospital; Dept of Medicine.

During the past decade, Queen Mary Hospital; Dept of Medicine conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen Mary Hospital; Dept of Medicine" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Hospital Authority, Hong Kong" with 2 trials sponsored, "Galapagos NV" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Mary Hospital; Dept of Medicine" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Queen Mary Hospital; Dept of Medicine" are "Breast Cancer" (2 trials), "Triple Negative Breast Cancer" (2 trials), "Advanced Breast Cancer" (1 trials), "Advanced Malignant Solid Tumors" (1 trials) and "B-cell Lymphoma" (1 trials). Many other conditions were trialed in "Queen Mary Hospital; Dept of Medicine" in a lesser frequency.

Most popular intervention types in "Queen Mary Hospital; Dept of Medicine" are "Drug" (15 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (5 trials), "Placebo" (4 trials), "Atezolizumab" (2 trials), "Carboplatin" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Queen Mary Hospital; Dept of Medicine" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Queen Mary Hospital; Dept of Medicine". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Queen Mary Hospital; Dept of Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Queen Mary Hospital; Dept of Medicine, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".